Cornerstone Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Cornerstone Advisory's VRTX Position: Q2 2026 in Review
Cornerstone Advisory opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 408 shares worth $203K. The stake represents 0.02% of the portfolio and ranks #268 among its holdings. This is a return to the name: Cornerstone Advisory previously reported a position in VRTX as recently as Q4 2021.
Cornerstone Advisory first reported a position in VRTX in Q4 2021 and has held it in 2 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Cornerstone Advisory held 408 shares of Vertex Pharmaceuticals worth $203K as of Q2 2026.
- Vertex Pharmaceuticals was a new Cornerstone Advisory position in Q2 2026.
- Vertex Pharmaceuticals made up 0.02% of Cornerstone Advisory's portfolio in Q2 2026, its #268 holding.
- Cornerstone Advisory first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 2 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.